Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLYCD | O95822 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | MIF | P14174 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL219603 | 0.87 | SMN1; SMN2 (0.49) | MLYCDCYP3A4ALDH1A1MEN1CYP2C9 | |
| SCHEMBL1826174 | 0.86 | MLYCD (0.44) | MLYCDALDH1A1MIF | |
| SCHEMBL266144 | 0.86 | MT-CO2 (0.46) | MLYCDCYP3A4ALDH1A1MIFMEN1 | |
| SCHEMBL2929114 | 0.86 | MLYCD (0.38) | MLYCDMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL11648528 | 0.86 | MLYCD (0.38) | MLYCDCYP3A4MEN1CYP2C9CYP2C19 | |
| SCHEMBL3349318 | 0.86 | MLYCD (0.41) | MLYCDMEN1KMT2A | |
| SCHEMBL3375082 | 0.86 | MLYCD (0.38) | MLYCDCYP3A4MEN1CYP2C9CYP2C19 | |
| SCHEMBL11052501 | 0.86 | NQO2 (0.39) | MEN1CYP2C9KMT2A | |
| SCHEMBL3660817 | 0.85 | KEAP1 (0.49) | — | |
| SCHEMBL8333179 | 0.85 | CA12 (0.41) | MLYCDALDH1A1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0593615-B1 | AROMATIC COMPOUNDS, COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY | MERCK SHARP & DOHME (GB) | 1996-01-31 | — | — | EP | claimed |
| JP-61040291-A | — | — | None | — | — | JP | disclosed |
| EP-1427423-B9 | BENZOTHIAZEPINE AND BENZOTHIADIAZEPINE DERIVATIVES WITH ILEAL BILE ACID TRANSPORT (IBAT) INHIBITORY ACTIVITY FOR THE TREATMENT HYPERLIPIDAEMIA | ASTRAZENECA AB (SE) | 2017-12-20 | — | — | EP | disclosed |
| US-9364424-B2 | Topical cosmetic skin lightening compositions and methods of use thereof | STIEFEL LABORATORIES, INC. (US) | 2016-06-14 | — | — | US | disclosed |
| US-20160074315-A1 | TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF | STIEFEL LABORATORIES, INC. | 2016-03-17 | — | — | US | disclosed |
| US-8907092-B2 | Inhibitors of IAP | GENENTECH, INC. (US) | 2014-12-09 | — | — | US | disclosed |
| US-8586542-B2 | Small molecule apoptosis promoters | JOYANT PHARMACEUTICALS, INC. (US) | 2013-11-19 | — | — | US | disclosed |
| US-20130281385-A1 | SMALL MOLECULE APOPTOSIS PROMOTERS | JOYANT PHARMACEUTICALS, INC. | 2013-10-24 | — | — | US | disclosed |
| US-8222291-B2 | Small molecule apoptosis promoters | JOYANT PHARMACEUTICALS, INC. (US) | 2012-07-17 | — | — | US | disclosed |
| US-20120082640-A1 | Small molecule apoptosis promoters | JOYANT PHARMACEUTICALS, INC. | 2012-04-05 | — | — | US | disclosed |
| US-4013764-A | PHARMACEUTICAL COMPOSITIONS COMPRISING SUBSTITUTED PHENYLGLYCYLCEPHALOSPORINS AND METHODS OF TREATING BACTERIAL INFECTIONS | SMITHKLINE CORPORATION (US) | 1977-03-22 | — | — | US | disclosed |
| US-3987041-A | P-HYDROXYMETHYLPHENYLACETAMIDOCEPHALOSPORINS | SMITHKLINE CORPORATION (US) | 1976-10-19 | — | — | US | disclosed |
| US-3985739-A | 3-Heterocyclic thiomethylcephalosporins | SMITHKLINE CORPORATION (US) | 1976-10-12 | — | — | US | disclosed |
| US-3972919-A | CHEMICAL INTERMEDIATE FOR ANTIBIOTICS | SMITHKLINE CORPORATION (US) | 1976-08-03 | — | — | US | disclosed |
| US-3968226-A | 3-Heterocyclic thiomethylcephalosporins as antibacterial agents | SMITHKLINE CORPORATION (US) | 1976-07-06 | — | — | US | disclosed |
| US-3962230-A | BACTERICIDES | SMITHKLINE & FRENCH LABORATORIES, INC. (US) | 1976-06-08 | — | — | US | disclosed |
| US-3957768-A | BACTERICIDES | SMITHKLINE CORPORATION (US) | 1976-05-18 | — | — | US | disclosed |
| US-3953439-A | ANTIBACTERIAL | SMITHKLINE CORPORATION (US) | 1976-04-27 | — | — | US | disclosed |
| US-3946005-A | BACTERICIDES | SMITHKLINE CORPORATION (US) | 1976-03-23 | — | — | US | disclosed |
| US-3943129-A | BACTERICIDE | SMITHKLINE CORPORATION (US) | 1976-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130281385-A1 | SMALL MOLECULE APOPTOSIS PROMOTERS | BID, BAD, BAX | MLYCD 1009/4885CYP3A4 4868/4885ALDH1A1 4619/4885 |
| US-20120082640-A1 | Small molecule apoptosis promoters | BID, BAD, BAX | MLYCD 1009/4885CYP3A4 4868/4885ALDH1A1 4619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.